{
    "015fb8ac-b273-3841-9ae9-937c0045e43d": {
        "uuid": "015fb8ac-b273-3841-9ae9-937c0045e43d",
        "title": "10 Best Healthcare Stocks to Buy in 2022 According to Hedge Funds",
        "publisher": "Insider Monkey",
        "link": "https://finance.yahoo.com/news/10-best-healthcare-stocks-buy-132522047.html",
        "providerPublishTime": 1653917122,
        "type": "STORY"
    },
    "cc29c585-e3b0-361c-847f-2732f8bf57e1": {
        "uuid": "cc29c585-e3b0-361c-847f-2732f8bf57e1",
        "title": "3 Dividend Stocks You Can Buy and Hold Forever",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/cc29c585-e3b0-361c-847f-2732f8bf57e1/3-dividend-stocks-you-can-buy.html",
        "providerPublishTime": 1653823860,
        "type": "STORY"
    },
    "3c45aa24-0be8-39cb-9fc4-ae91bc71a73b": {
        "uuid": "3c45aa24-0be8-39cb-9fc4-ae91bc71a73b",
        "title": "What Kind Of Shareholders Hold The Majority In AbbVie Inc.'s (NYSE:ABBV) Shares?",
        "publisher": "Simply Wall St.",
        "link": "https://finance.yahoo.com/news/kind-shareholders-hold-majority-abbvie-143608645.html",
        "providerPublishTime": 1653662168,
        "type": "STORY"
    },
    "b1eedb1d-8551-3bc0-aba1-3b4e5cc28b6a": {
        "uuid": "b1eedb1d-8551-3bc0-aba1-3b4e5cc28b6a",
        "title": "The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ\u00ae) in Ulcerative Colitis",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/lancet-publishes-results-phase-3-071500315.html",
        "providerPublishTime": 1653635700,
        "type": "STORY"
    },
    "9d2fda01-507a-3e35-9a14-0c01d2665d9a": {
        "uuid": "9d2fda01-507a-3e35-9a14-0c01d2665d9a",
        "title": "The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Risankizumab (SKYRIZI\u00ae) in Crohn's Disease",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/lancet-publishes-results-phase-3-070000423.html",
        "providerPublishTime": 1653634800,
        "type": "STORY"
    },
    "880a8385-0a01-3512-be41-8b614a8ab15f": {
        "uuid": "880a8385-0a01-3512-be41-8b614a8ab15f",
        "title": "7 High-Yield Retirement Stocks to Buy for Your Nest Egg",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/7-high-yield-retirement-stocks-220022572.html",
        "providerPublishTime": 1653602422,
        "type": "STORY"
    },
    "077348f9-154c-30c0-827c-63f53b34702c": {
        "uuid": "077348f9-154c-30c0-827c-63f53b34702c",
        "title": "AbbVie's Correction Appears to Be Over: Here's Where the Stock Could Be Headed",
        "publisher": "TheStreet.com",
        "link": "https://finance.yahoo.com/m/077348f9-154c-30c0-827c-63f53b34702c/abbvie%27s-correction-appears.html",
        "providerPublishTime": 1653589140,
        "type": "STORY"
    },
    "04fe5039-1487-3ef4-8b96-722a5b04f059": {
        "uuid": "04fe5039-1487-3ef4-8b96-722a5b04f059",
        "title": "7 Ideal Dividend Stocks to Buy for a Rich Retirement",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/7-ideal-dividend-stocks-buy-144113209.html",
        "providerPublishTime": 1653576073,
        "type": "STORY"
    }
}